AUSTRAL Dx
PrivateLast Round
Seed
Jul 24, 2025
Est. Valuation
$7.37M
Total Funding Raised
$4.74M
Company Overview
AUSTRAL Dx operates in Healthcare & Life Sciences and is based in Paris. Its latest recorded funding round was a Seed round in July 2025.
AUSTRAL Dx is a diagnostic equipment company that develops a device utilizing non-invasive, airborne ultrasound analysis to screen, diagnose, and monitor cardiac and pulmonary conditions.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical Devices, Medical AI
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AUSTRAL Dx Comparables
Compare AUSTRAL Dx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Acorai | 78% | |
| EchoNous | 67% | |
| Clarius Mobile Health | 65% |
For institutional investors. Book with your work email.
AUSTRAL Dx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 24, 2025 | ||||
| Crowdfunding | Jun 2, 2025 |
For institutional investors. Book with your work email.
AUSTRAL Dx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kima Ventures | Crowdfunding, Seed |
| Super Capital | Seed |
| Région Sud Investissement | Seed |
| Paris Business Angels | Crowdfunding, Seed |
| Angels Santé | Crowdfunding, Seed |
| Better Angle | Crowdfunding, Seed |
| iXcore | Crowdfunding, Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2026
Grew 25% QoQ, from 12 to 15 employees.
- Oct 16, 2025
Grew 33% QoQ from 9 to 12 employees.
For institutional investors. Book with your work email.
AUSTRAL Dx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AUSTRAL Dx's valuation, stock price, and market status.
Is AUSTRAL Dx a public or private company?
AUSTRAL Dx is a private company.
What is the current stock price of AUSTRAL Dx?
AUSTRAL Dx is a private company, so its shares have no public market price. Caplight tracks AUSTRAL Dx's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AUSTRAL Dx worth (valuation)?
AUSTRAL Dx's valuation is estimated at $7.4M based on funding round data.
Can I buy AUSTRAL Dx stock?
AUSTRAL Dx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AUSTRAL Dx's last funding round?
AUSTRAL Dx's most recent funding round was Seed on July 24, 2025.
Who are the main investors in AUSTRAL Dx?
Key investors in AUSTRAL Dx include Sorbonne Venture, Aloe Private Equity.
Will AUSTRAL Dx IPO soon?
No public IPO plans have been announced for AUSTRAL Dx.
How can I track AUSTRAL Dx secondary market activity?
Caplight tracks bids, offers, and trades in AUSTRAL Dx's shares on secondary markets.